Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

Citations Over TimeTop 1% of 2003 papers

Abstract

The lack of a control group in the present study does not allow any definite conclusions to be drawn regarding the clinical effectiveness of colistin. On the other hand, this drug has an acceptable safety profile and its use should be considered in severe infections with multiresistant Gram-negative bacilli.

Related Papers

• → Rapid method for distinction of gram-negative from gram-positive bacteria(1978)935 cited
• → Graphene oxide exhibits differential mechanistic action towards Gram-positive and Gram-negative bacteria(2019)136 cited
• → Significance of the Characteristic Chemical Pattern of Gram Positive and Gram Negative Bacterial Cell Walls(1967)8 cited
• → Antibacterial activity of Withania somnifera leaf extracts against gram-positive and gram-negative bacteria.(2018)4 cited
• [Evaluation of a method of differentiating Gram-positive and Gram-negative bacteria using a 3% solution of KOH].(1982)